- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: semaglutide
Total 410 results
-
Novo Nordisk A/SCompletedObesityUnited Kingdom, Canada, Denmark, Finland, Spain
-
University College, LondonActive, not recruitingObesity | Diabetes | Metabolic SyndromeUnited Kingdom
-
Imperial College LondonCompleted
-
Axel BrandesHillerod Hospital, Denmark; Herlev and Gentofte Hospital; Svendborg Hospital; Hospital...WithdrawnAtrial Fibrillation | Overweight and Obesity
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Healthy ParticipantsUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Germany
-
Lundquist Institute for Biomedical Innovation at...CompletedCoronary Artery Disease | Type 2 DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Serbia, South Africa, Taiwan, Romania, Algeria, Hong Kong, Brazil, China, Czechia
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedType 2 Diabetes | Healthy VolunteersUnited States, Canada
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Taiwan, Serbia, Algeria, Hungary, China, Ukraine
-
University Medical Centre LjubljanaCompletedPCOS | Gastric Emptying | Semaglutide | Taste, Altered | Tongue Tissue Transcriptome | Central Neural ResponseSlovenia
-
Novo Nordisk A/SCompletedOverweight and ObesityJapan, Korea, Republic of
-
Novo Nordisk A/SCompletedHealthy VolunteersGermany
-
Brigham and Women's HospitalCompletedDiabetes Mellitus, Type 2United States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States
-
Brigham and Women's HospitalJohns Hopkins University; National Institute on Aging (NIA); Rutgers UniversityActive, not recruiting
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, Italy, Spain, Canada, Hungary
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedObesity | Diabetes Mellitus, Type 2 | OverweightKorea, Republic of, Hong Kong, Brazil, China
-
Novo Nordisk A/SEli Lilly and Company; AstraZeneca; United BioSource, LLCEnrolling by invitationDiabetes Mellitus, Type 2 | Diabetes | Weight Management | Medullary Thyroid CarcinomaUnited States
-
Sansum Diabetes Research InstituteNovo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | Glucose Metabolism Disorders (Including Diabetes Mellitus)United States
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States
-
Novo Nordisk A/SCompletedHealthy Volunteers Type 2 DiabetesJapan
-
General and Teaching Hospital CeljeCompletedDiabetes Mellitus, Type 1 | Biomarkers | Endothelial Dysfunction | Arterial Stiffness | FMD | Incretins | Endothelial Progenitor Cells | SGLT 2 Inhibitors | Glucose Excursions | FPFSlovenia
-
Novo Nordisk A/SCompletedHealthy Volunteers Type 2 DiabetesUnited Kingdom
-
University of MiamiCompleted
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompleted
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Germany
-
James J. Peters Veterans Affairs Medical CenterKessler Institute for RehabilitationCompletedObesity | Insulin Resistance | Spinal Cord Injuries | Pre DiabetesUnited States
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Poland, Puerto Rico, Canada, Hungary, Greece, Japan, Bulgaria, Slovakia, Ukraine, Czechia
-
Michael John RobertsonNovartisCompletedNon-Hodgkin's LymphomaUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Healthy VolunteersChina
-
Novo Nordisk A/SCompleted
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)Active, not recruitingInsulin Resistance | Adiposity | Hepatic Steatosis | HIV-1-infection | Pre-diabetesUnited States, Brazil
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Germany, Spain, Taiwan, Hungary, Poland, Korea, Republic of, Austria, New Zealand, United Kingdom, Czechia, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Croatia, India, Poland, Spain, Serbia, Germany, Slovakia, Slovenia, Turkey, Hungary, Greece, Czechia, Bulgaria, South Africa, Romania, Bosnia and Herzegovina, Estonia, Portugal, Latvia, Lithuania, North Macedonia
-
Novo Nordisk A/SWithdrawn
-
University Health Network, TorontoNovo Nordisk A/SEnrolling by invitationDiabetes Mellitus | NAFLD | NASH - Nonalcoholic Steatohepatitis | Liver Transplant; ComplicationsCanada
-
Novo Nordisk A/SCompletedObesity | Diabetes Mellitus, Type 2 | Overweight | Healthy VolunteersNetherlands
-
San Francisco Veterans Affairs Medical CenterSuspendedObesity | Overweight | Atrial FibrillationUnited States
-
Region SkaneGöteborg UniversityActive, not recruitingType2 DiabetesSweden
-
Novo Nordisk A/SWithdrawn
-
Novo Nordisk A/SCompletedType 2 Diabetes | Healthy VolunteersGermany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Russian Federation, Mexico, Japan, Serbia, Turkey, Italy, Czechia, Bulgaria, Algeria, Romania